Physician's Main :: MOA

In tune with the body's own processes of bone resorption and remodeling

Fortical® Nasal Spray works to help
restore harmonious balance*

  • Fortical® Nasal Spray has been shown to rapidly
    decrease bone resorption markers as early as 1 month5

  • In vitro studies have shown that calcitonin-salmon
    inhibits osteoclast function and may augment bone
    formation through increased osteoblast activity1

  • Calcitonin-salmon has been shown to preserve
    or improve trabecular microarchitecture§6

*Although not completely elucidated, the mechanism of action depicted in this
simplified graphic represents a complex continuous process. Calcitonin-salmon
is intended to be used as long-term therapy.

HOME | PRESCRIBING INFORMATION | CORPORATE | PRIVACY POLICY | LEGAL NOTICES


IMPORTANT SAFETY INFORMATION
Indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause with low bone mass relative to healthy premenopausal women. Recommended in conjunction with adequate calcium and vitamin D intake. The most common adverse events were rhinitis, other nasal symptoms, back pain, arthralgia, epistaxis, and headache. Periodic nasal examinations are recommended; if nasal ulceration occurs, discontinue treatment until healed. Because calcitonin-salmon is a protein, the possibility of systemic allergic reaction exists. Please refer to full prescribing information.